{"id":"W2753841357","doi":"10.1093/annonc/mdx514","title":"Meta-analysis of individual patient safety data from six randomized, placebo-controlled trials with the antiangiogenic VEGFR2-binding monoclonal antibody ramucirumab","year":2017,"lang":"en","type":"review","venue":"Annals of Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"National Institute for Health and Care Research; Eli Lilly and Company","keywords":"Ramucirumab; Medicine; Placebo; Oncology; Monoclonal antibody; Internal medicine; Randomized controlled trial; Bevacizumab; Monoclonal; VEGF receptors; Antibody; Chemotherapy; Immunology; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.01000004,0.0007704698,0.04147469,0.0006696228,0.000239516,0.00004513245,0.001117335,0.0004272689,0.000750295],"category_scores_gemma":[0.002662028,0.0003216639,0.01119756,0.0004680704,0.0007087578,0.0001022052,0.0006711187,0.0003850838,0.000008208411],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007317981,"about_ca_system_score_gemma":0.001288959,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000546071,"about_ca_topic_score_gemma":0.0005034666,"domain_scores_codex":[0.9904281,0.003995254,0.003396203,0.000871796,0.0008751206,0.0004335085],"domain_scores_gemma":[0.9743212,0.01530778,0.007814096,0.002011377,0.0004257614,0.0001197551],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.11294,0.0003602133,0.000006977297,0.0003464193,0.6588858,0.00005641462,0.0002521369,0.000003172569,4.891355e-7,0.00001308581,0.001076014,0.2260592],"study_design_scores_gemma":[0.07460646,0.001309306,0.00002271048,0.0003301002,0.6507987,0.00001135696,0.0000842427,0.00001231091,0.000002797761,0.000005944233,0.2726358,0.0001802769],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0007277799,0.9821094,0.00002071194,0.001357751,0.000179211,0.005642736,0.008472958,0.00001210265,0.001477379],"genre_scores_gemma":[0.00569463,0.9870998,0.0002113454,0.0001531376,0.000159036,0.0005981321,0.005867615,0.0000427182,0.0001736129],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.2715597,"threshold_uncertainty_score":0.9999235,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.5467726718018913,"score_gpt":0.5184122577197179,"score_spread":0.02836041408217338,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}